Substituted piperidines as melanocortin receptor agonists

Details for Australian Patent Application No. 2001288285 (hide)

Owner Merck & Co., Inc.

Inventors Park, Min K.; Sebhat, Iyassu; Nargund, Ravi P.; Lai, Yingjie; Bakshi, Raman K.; Ye, Zhixiong; Palucki, Brenda L.; Patchett, Arthur A.; Barakat, Khaled J

Agent Spruson & Ferguson

Pub. Number AU-B-2001288285

PCT Pub. Number WO02/15909

Priority 60227180 23.08.00 US

Filing date 17 August 2001

Wipo publication date 4 March 2002

Acceptance publication date 29 September 2005

International Classifications

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/4523 - containing further heterocyclic ring systems

C07D 413/02 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 401/02 Heterocyclic compounds containing two or more hetero rings

C07D 211/06 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 417/02 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

29 September 2005 Application Accepted

  Published as AU-B-2001288285

2 February 2006 Standard Patent Sealed

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288286-Methods for treating demyelinating diseases

2001288284